These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 7213374
1. Vitamin K1 hydroquinone formation catalyzed by a microsomal reductase system. Fasco MJ, Principe LM. Biochem Biophys Res Commun; 1980 Dec 31; 97(4):1487-92. PubMed ID: 7213374 [No Abstract] [Full Text] [Related]
2. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats. Hallak HO, Wedlund PJ. Drug Metab Dispos; 1991 Dec 31; 19(1):278-9. PubMed ID: 1673414 [No Abstract] [Full Text] [Related]
3. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats. Nutr Rev; 1983 Aug 31; 41(8):253-4. PubMed ID: 6355923 [No Abstract] [Full Text] [Related]
4. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats. Fasco MJ, Preusch PC, Hildebrandt E, Suttie JW. J Biol Chem; 1983 Apr 10; 258(7):4372-80. PubMed ID: 6833262 [Abstract] [Full Text] [Related]
5. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition. Wilson CR, Sauer JM, Carlson GP, Wallin R, Ward MP, Hooser SB. Toxicology; 2003 Aug 01; 189(3):191-8. PubMed ID: 12832152 [Abstract] [Full Text] [Related]
6. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance. Preusch PC, Suttie JW. J Nutr; 1984 May 01; 114(5):902-10. PubMed ID: 6726460 [Abstract] [Full Text] [Related]
7. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction. Lee JJ, Principe LM, Fasco MJ. Biochemistry; 1985 Dec 03; 24(25):7063-70. PubMed ID: 4084561 [Abstract] [Full Text] [Related]
8. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase. Creedon KA, Suttie JW. Thromb Res; 1986 Oct 15; 44(2):147-53. PubMed ID: 3787564 [Abstract] [Full Text] [Related]
10. Characterization and purification of the vitamin K1 2,3 epoxide reductases system from rat liver. Begent LA, Hill AP, Steventon GB, Hutt AJ, Pallister CJ, Cowell DC. J Pharm Pharmacol; 2001 Apr 10; 53(4):481-6. PubMed ID: 11341364 [Abstract] [Full Text] [Related]
11. Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle. Guenthner TM, Cai D, Wallin R. Biochem Pharmacol; 1998 Jan 15; 55(2):169-75. PubMed ID: 9448739 [Abstract] [Full Text] [Related]
12. Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity. Thijssen HH, Drittij-Reijnders MJ. Br J Haematol; 1993 Aug 15; 84(4):681-5. PubMed ID: 8217828 [Abstract] [Full Text] [Related]
13. Vitamin K epoxide reductase activity in the metabolism of epoxides. Liptay-Reuter I, Dose K, Guenthner T, Wörner W, Oesch F. Biochem Pharmacol; 1985 Aug 01; 34(15):2617-20. PubMed ID: 4015704 [Abstract] [Full Text] [Related]
14. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats. Yamanaka Y, Yamano M, Yasunaga K, Shike T, Uchida K. Thromb Res; 1990 Jan 15; 57(2):205-14. PubMed ID: 2315885 [Abstract] [Full Text] [Related]